Bernd Brust has been promoted by Invitrogen to the newly established position of senior vice president of sales for Europe and the Americas. Brust has been serving as general manager and vice president of European operations, a post that will now be assumed by Susan Lambert.
Brust joined Invitrogen in 2004 from GE, where he served as general manager, sales and marketing, for GE Medical Systems Information Technologies.
Heiner Dreismann has been named to the board of directors at Nanogen, the company said last week.
Dreismann is the current CEO of FasTraQ and previously served as president and CEO of Roche Molecular Systems.
Dreismann became a director of Iconix Biosciences last week and last month became a director of GeneNews, formerly ChondroGene.